Chocolate Wrapping Machine,Automatic Twist Packing Machine,Hard Candy Double Twist Packing Machine,Chocolate Top Single Twist Packing NANTONG WEALTH , https://www.wealthfoodsmachine.com
Financial Tsunami Difficult to Add 200 Billion Chinese Domestic Demand for Pharmaceutical Enterprises
Under cover, do you have eggs? The global financial crisis has ravaged the world, and industries such as automobiles, finance, and real estate are in jeopardy. However, the domestic pharmaceutical industry is fragrant and fragrant. The landscape is good.
According to the National Development and Reform Commission announced on October 30 the first three quarters of this year, the major industrial industries showed that the pharmaceutical industry maintained rapid growth in production and efficiency.
"Drug products are different from high-end nutritional products, automobiles, and other consumer products. No matter if the economy is depressed or not, people will get sick. If you fall sick, you have to take medicine. The demand for medicines is rigid." A marketing director of a pharmaceutical company in China who declined to be named In an interview with a reporter from the “China Sankei Shimbunâ€, Mr. Gao said that the financial crisis had little impact on the operating performance of the pharmaceutical companies in which it was located.
According to Wind statistics, in the third quarter of this year, the performance of nearly 70% of pharmaceutical companies has increased. Among the 129 listed pharmaceutical companies, 87 companies reported a year-on-year increase in net profit in the third quarter, accounting for nearly 70% of the total. Stimulated by the increase in product prices, the performance of the chemical and pharmaceutical industry showed a high growth trend. At the same time, there are 21 companies in the third quarter net profit increased by more than 100%. From the growth figures, it is not difficult to see that, despite the global economic downturn, the domestic pharmaceutical companies have seen a significant increase in contrarian prices.
The huge domestic population base, the patient population, and the reform of the medical system have made the scale of medical consumption continue to expand, and the pharmaceutical industry has attracted more attention.
In China, there are more than 2 billion hospital outpatient visits each year and nearly 80 million people receive hospitalization. According to the data, driven by the expansion of medical insurance coverage, the sales revenue of the industry in the first five months of 2008 increased by 32.11%, the profit growth rate reached 51.63%, and the gross profit rate increased by 0.6% to 31.73%.
Xinhua Finance, a report entitled "China's Pharmaceutical Industry Credit Trend Outlook," said: "The Chinese government's efforts to strengthen health care investment and improve the medical security system in recent years have helped accelerate the release of domestic demand for the pharmaceutical industry. Measures such as medical reform plans to deepen the reform of the medical and health system will further consolidate this trend."
Lin Jianning, director of the Southern Food and Economic Research Institute of the State Food and Drug Administration, pointed out that by 2010, the government will raise about 400 billion yuan in medical funds, which will be measured as 48.8% of drug costs. In theory, it will increase directly after 3 years. The pharmaceutical market demand is nearly 200 billion yuan.
However, Wu Huifang, chief researcher and general manager of Health Network, told reporters of the “China Sankei Shimbunâ€: “Domestic pharmaceutical companies must be prepared in times of danger. Some export-oriented pharmaceutical companies should be vigilant.â€